News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
630,160 Results
Type
Article (54901)
Company Profile (80)
Press Release (575179)
Section
Business (172326)
Career Advice (2755)
Deals (32467)
Drug Delivery (94)
Drug Development (77156)
Employer Resources (160)
FDA (14895)
Job Trends (13844)
News (304234)
Policy (29221)
Tag
Academia (2574)
Alliances (42189)
Alzheimer's disease (1156)
Approvals (14855)
Artificial intelligence (149)
Bankruptcy (283)
Best Places to Work (10818)
Breast cancer (180)
Cancer (1331)
Cardiovascular disease (103)
Career advice (2331)
CAR-T (96)
Cell therapy (288)
Clinical research (61764)
Collaboration (459)
Compensation (158)
COVID-19 (2385)
C-suite (120)
Data (1354)
Diabetes (157)
Diagnostics (5950)
Earnings (59272)
Employer resources (140)
Events (93935)
Executive appointments (406)
FDA (15563)
Funding (403)
Gene therapy (191)
GLP-1 (562)
Government (4411)
Healthcare (18179)
Infectious disease (2470)
Inflammatory bowel disease (110)
Interviews (526)
IPO (14695)
Job creations (3407)
Job search strategy (1963)
Layoffs (448)
Legal (6441)
Lung cancer (190)
Lymphoma (97)
Manufacturing (190)
Medical device (12476)
Medtech (12481)
Mergers & acquisitions (17977)
Metabolic disorders (415)
Neuroscience (1461)
NextGen Class of 2024 (6412)
Non-profit (4425)
Northern California (1531)
Obesity (232)
Opinion (210)
Patents (114)
People (57697)
Phase I (19268)
Phase II (27164)
Phase III (20064)
Pipeline (486)
Postmarket research (2529)
Preclinical (8228)
Radiopharmaceuticals (244)
Rare diseases (249)
Real estate (5906)
Regulatory (19768)
Research institute (2241)
Resumes & cover letters (413)
Southern California (1343)
Startups (3230)
United States (13777)
Vaccines (534)
Weight loss (161)
Date
Last 7 days (578)
Last 30 days (2240)
Last 365 days (32379)
2024 (32235)
2023 (36412)
2022 (46648)
2021 (51480)
2020 (50555)
2019 (44780)
2018 (34066)
2017 (30434)
2016 (29749)
2015 (35018)
2014 (28187)
2013 (24431)
2012 (25782)
2011 (26098)
2010 (24826)
Location
Africa (846)
Arizona (136)
Asia (36539)
Australia (6440)
California (3419)
Canada (1306)
China (282)
Colorado (160)
Connecticut (171)
Europe (85278)
Florida (491)
Georgia (129)
Illinois (395)
Indiana (203)
Maryland (605)
Massachusetts (2534)
Michigan (172)
Minnesota (246)
New Jersey (1037)
New York (968)
North Carolina (742)
Northern California (1531)
Ohio (134)
Pennsylvania (819)
South America (1183)
Southern California (1343)
Texas (507)
Utah (105)
Washington State (359)
630,160 Results for "american college of cardiology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anumana Joins the American College of Cardiology to Advance AI-Powered Solutions for Detecting Heart Failure
December 12, 2024
·
3 min read
Lone Star Bio
Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology
Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of Cardiology: Heart Failure has published a research paper concluding that INPEFA® is cost-effective for people with diabetes and recent worsening heart failure using commonly accepted willingness-to-pay thresholds.
June 18, 2024
·
10 min read
Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the American College of Cardiology (ACC.24) at the Georgia World Congress Center in Atlanta, GA, April 6 – 8, 2024.
April 1, 2024
·
3 min read
Biotech Beach
egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
egnite, Inc., a leading digital health company for cardiovascular care, and JenaValve Technology, Inc., a developer and manufacturer of differentiated transcatheter aortic valve replacement systems, unveil a novel study presented at the American College of Cardiology’s Annual Scientific Session & Expo.
April 6, 2024
·
4 min read
Edgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology’s 2024 Annual Scientific Session
Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the Company will present data on EDG-7500 at the American College of Cardiology’s Annual Scientific Session (ACC.24).
March 28, 2024
·
3 min read
Pharm Country
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
Amarin Corporation plc (NASDAQ:AMRN) today announced that additional patient subgroup analyses from the landmark REDUCE-IT outcomes trial and mechanistic data on icosapent ethyl (IPE)/eicosapentaenoic acid (EPA) will be presented at the American College of Cardiology’s Annual Scientific Session & Expo, April 6 – 8, 2024 in Atlanta, GA.
March 25, 2024
·
10 min read
News
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
October 21, 2024
·
4 min read
Biotech Bay
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four presentations at the American College of Cardiology 73rd Annual Scientific Session (ACC.24) taking place in Atlanta, GA from April 6, 2024 – April 8, 2024.
March 25, 2024
·
4 min read
BioMidwest
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session
Cardio Diagnostics Holdings, Inc. announces that the Company will showcase its groundbreaking HeartRisk TM and Actionable Clinical Intelligence TM platforms at the American College of Cardiology’s 73rd Annual Scientific Session (ACC.24), taking place in Atlanta, GA, from April 6-8, 2024.
March 14, 2024
·
5 min read
Drug Development
American College of Cardiology Presentation Highlights Promising Results Showing Potential to Reduce Coronary Inflammation with Abcentra’s Orticumab
Abcentra LLC, a clinical-stage biopharmaceutical company specializing in coronary artery disease, presented the latest results from a Phase 2a pilot, placebo-controlled, randomized clinical trial of Orticumab, a new drug with a novel mechanism of action to combat coronary inflammation, at the American College of Cardiology (ACC) Annual Scientific Sessions in Atlanta.
April 8, 2024
·
5 min read
1 of 63,016
Next
